Sana suspends work on allogeneic CAR-T; Biokin eyes $387M raise in Hong Kongnews2025-11-07T15:27:39+00:00November 7th, 2025|Endpoints News|
ObesityWeek rode the momentum of the field’s most dramatic week in monthsnews2025-11-07T14:30:19+00:00November 7th, 2025|Endpoints News|
Lilly hires Denali executive to run neuroscience divisionnews2025-11-07T14:02:21+00:00November 7th, 2025|Endpoints News|
#AASLD25: Rivus’ MASH drug cuts liver fat, preserves muscle in mid-stage trialnews2025-11-07T13:00:37+00:00November 7th, 2025|Endpoints News|
Novo Nordisk, Pfizer make personnel waves as they squabble over Metseranews2025-11-07T12:00:59+00:00November 7th, 2025|Endpoints News|
Onchilles raises $25M to take cancer-killing enzyme into human studiesnews2025-11-07T12:00:14+00:00November 7th, 2025|Endpoints News|
Eccogene targets $150M in HKEX listing for MASH, obesity drugsnews2025-11-07T11:30:06+00:00November 7th, 2025|Endpoints News|
Patient in Intellia CRISPR trial dies after being hospitalized with liver injurynews2025-11-07T02:34:55+00:00November 7th, 2025|Endpoints News|
Evommune CEO talks about sticking with $150M IPO plan during government shutdownnews2025-11-07T00:28:59+00:00November 7th, 2025|Endpoints News|
Zuckerberg-backed Biohub hires EvolutionaryScale team in apparent end of AI startupnews2025-11-07T00:06:20+00:00November 7th, 2025|Endpoints News|
